Immatics (IMTX) Enterprise Value Growth (1y) (2020 - 2025)
Immatics (IMTX) Enterprise Value Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.42% |
| Sep 30, 2025 | 6.50% |
| Jun 30, 2025 | 5.36% |
| Mar 31, 2025 | 6.64% |
| Dec 31, 2024 | -40.96% |
| Sep 30, 2024 | -35.20% |
| Jun 30, 2024 | -43.61% |
| Mar 31, 2024 | -73.07% |
| Dec 31, 2023 | -24.00% |
| Sep 30, 2023 | -27.75% |
| Jun 30, 2023 | -15.06% |
| Mar 31, 2023 | -24.80% |
| Dec 31, 2022 | -122.60% |
| Sep 30, 2022 | -52.69% |
| Jun 30, 2022 | -49.07% |
| Mar 31, 2022 | -8.54% |
| Dec 31, 2021 | 39.98% |
| Sep 30, 2021 | 32.56% |
| Jun 30, 2021 | -146.41% |
| Mar 31, 2021 | 22.03% |